Muimo, R. orcid.org/0000-0003-4242-0188 (2017) Classical activation of macrophages and vardenafil. Clinical Science, 131 (11). pp. 1141-1145. ISSN 0143-5221
Abstract
Inhibitors of phosphodiesterase 5 (PDE5) - sildenafil citrate (Viagra; Pfizer) and vardenafil hydrochloride (Levitra; Bayer/GlaxoSmithKline) - approved for the treatment of erectile dysfunction and pulmonary arterial hypertension also rescue the loss of cystic fibrosis (CF) chloride channel function and the mislocalization of F508del-CFTR in affected tissues in CF. Can PDE5 inhibitors provide a therapeutic strategy which combines ability to correct the basic ion transport defect and to control de-regulated lung inflammation in CF?
Metadata
Item Type: | Article |
---|---|
Authors/Creators: |
|
Copyright, Publisher and Additional Information: | © 2017 Portland Press. This is an author produced version of a paper subsequently published in Clinical Science. Uploaded in accordance with the publisher's self-archiving policy. |
Keywords: | Immunology & Inflammation; Molecular Bases of Health & Disease; Molecular Interactions |
Dates: |
|
Institution: | The University of Sheffield |
Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease |
Depositing User: | Symplectic Sheffield |
Date Deposited: | 14 Dec 2017 10:51 |
Last Modified: | 03 Aug 2023 08:43 |
Status: | Published |
Publisher: | Portland Press |
Refereed: | Yes |
Identification Number: | 10.1042/CS20170137 |
Related URLs: | |
Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:125174 |